Krones Tanja, Richter Gerd
Philipps-University Marburg, Baldingerstr. 1, D-35033 Marburg, Germany.
J Med Philos. 2004 Oct;29(5):623-40. doi: 10.1080/03605310490514243.
This article gives an overview about the ethical dispute on preimplantation genetic diagnosis (PGD), its legal status and its practical usage in Europe. We provide a detailed description of the situation in Germany wherein prenatal diagnosis is routinely applied, but PGD is prohibited on the basis of the internationally unique embryo protection act (EPA) that was put into force in 1991. Both PGD and stem cell research were vigorously debated in Germany during the last four years. As regards the PGD debate specifically, the voices of the ones directly affected were not adequately taken into consideration. We describe the predominant lines of argumentation in this debate and some essential results of our "bioethical field study" of opinions on and usage of PGD in Germany and their implications for the German legislation and ethical theory.
本文概述了欧洲关于植入前基因诊断(PGD)的伦理争议、其法律地位及其实际应用。我们详细描述了德国的情况,在德国,产前诊断被常规应用,但基于1991年生效的具有国际独特性的胚胎保护法(EPA),PGD被禁止。在过去四年里,PGD和干细胞研究在德国都引发了激烈辩论。具体就PGD辩论而言,直接受影响者的声音没有得到充分考虑。我们描述了这场辩论中的主要论点,以及我们对德国关于PGD的观点和使用情况进行的“生物伦理实地研究”的一些重要结果,及其对德国立法和伦理理论的影响。